These molecules are prognostic markers of the progression of CLL and are known (apart from angiogenin) to be involved in the functional deregulation of CLL cells (i.e., with regard to survival, proliferation, and migration) [2,51,92,93,94,96,97] (Table 1). The gene discussed is ANG; the disease is B-cell chronic lymphocytic leukemia.